In last trading session, MBX Biosciences Inc (NASDAQ:MBX) saw 0.38 million shares changing hands with its beta currently measuring 0. Company’s recent per share price level of $10.01 trading at -$1.63 or -14.00% at ring of the bell on the day assigns it a market valuation of $334.51M. That closing price of MBX’s stock is at a discount of -174.73% from its 52-week high price of $27.50 and is indicating a premium of 5.89% from its 52-week low price of $9.42. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 0.28 million shares which gives us an average trading volume of 234.95K if we extend that period to 3-months.

MBX Biosciences Inc (NASDAQ:MBX) trade information

Upright in the red during last session for losing -14.00%, in the last five days MBX remained trading in the red while hitting it’s week-highest on Friday, 01/31/25 when the stock touched $10.01 price level, adding 15.81% to its value on the day. MBX Biosciences Inc’s shares saw a change of -45.69% in year-to-date performance and have moved -6.88% in past 5-day. MBX Biosciences Inc (NASDAQ:MBX) showed a performance of -44.11% in past 30-days. Number of shares sold short was 1.67 million shares which calculate 5.33 days to cover the short interests.

Wall Street analysts have assigned a consensus price target of 44 to the stock, which implies a rise of 77.25% to its current value. Analysts have been projecting 44 as a low price target for the stock while placing it at a high target of 44. It follows that stock’s current price would drop -339.56% in reaching the projected high whereas dropping to the targeted low would mean a loss of -339.56% for stock’s current value.